ArticleEuropean archives of psychiatry and clinical neuroscience2026
Short-term longitudinal changes in metabolic and cardiac parameters in inpatients with schizophrenia: the role of age and sex.
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAntipsychotic therapy in schizophrenia is associated with metabolic and cardiac adverse effects. However, the short-term trajectory of these parameters during controlled inpatient stabilization, and the moderating roles of age and sex, remain less clear.
methodsThis study enrolled 586 inpatients with schizophrenia; all stabilized on an unchanged antipsychotic regimen. Fasting blood glucose (FBG), lipid profiles [triglycerides (TG), Cholesterol (CHOL), high-density lipoprotein (HDL), low density lipoprotein (LDL)], and electrocardiogram (ECG) parameters (heart rate, QRS, PR, QTc) were measured at admission and discharge. Changes were analyzed using paired t-tests and multiple linear regression to assess the influence of age and sex.
resultsFrom admission to discharge, significant improvements were observed in FBG (mean change: - 0.56 ± 0.07 mmol/L, pFDR < 0.01) and heart rate (mean change: - 3.81 ± 0.92 bpm, pFDR < 0.01). A significant reduction in HDL was also found (mean change: - 0.11 ± 0.02 mmol/L, pFDR < 0.01). Age-stratified analysis revealed a significant QTc shortening exclusively in patients > 45 years old (p < 0.05). Regression analysis identified sex as a significant independent predictor of HDL change (β = 0.068, p = 0.016).
conclusionThe inpatient stabilization phase is a dynamic period marked by both beneficial (improved glycemia, lower heart rate) and adverse (reduced HDL) physiological changes. The differential effects based on age (QTc shortening) and sex (HDL change) underscore the necessity for personalized cardiometabolic monitoring and risk mitigation strategies in patients with schizophrenia.
Indexed as
Identifiers
41882387What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.